Hoyoung MM

#CancerImmunotherapy #CancerVaccine #BackyardVeggies #AutoimmuneDisease Alumna@ #DFLH (Fr) #Yonsei🔴Personal acct🍯Follows&RTs not endorsement.

[Hoyoung MM @hmaeng]

@hangul 대기오염 걱정하기 전에 cigar끊고 암예방하자.

[Hoyoung MM @hmaeng]

@FreedomKorea7 @Areallequal 그런다고 못보니 ㅎㅎㅎㅎ

[Hoyoung MM @hmaeng]

People had been saying “cancer immunotherapies do not work” for 30-40 years (until it worked).

No point of arguing when there are apparent evidences.

[Hoyoung MM @hmaeng]

@juseokkk 사랑한다 연대!

[Hoyoung MM @hmaeng]

@GordonGChang Thanks s much for raising voice. #SaveKorea

[Hoyoung MM @hmaeng]

@NiuSanford Entire Pubmed is part of NIH operation. If NIH operates a separate journal, that will become another government operation. JNCI was tied to NCI historically but not any more I believe.

[Hoyoung MM @hmaeng]

Was a postdoc candidate +20 yrs ago here @bcmhouston, now a collaborator/Baylor CAGT GMP vector lab. Many of my mentors have retired from Baylor and @MDAndersonNews but always good to visit the group who pioneered cellular therapies and see long time buddies thanks so #SITC2024.

[Hoyoung MM @hmaeng]

How to catch up with your IRB boss after seeing him on screen only for a long time! You find him at the poster!! (Or find him visiting your poster) #SITC2024 #CancerImmunotherapy @ArlenParlen

[Hoyoung MM @hmaeng]

💕When you meet someone who remembers what happened to you 20 years ago!!! Amazing to see Anna @MDAndersonNews and revisit good memories of the late Dr. Ki Hong from my alma mater @yonsei_u.

[U.S. Military Academy at West Point @WestPoint_USMA]

Never Forget

#PatriotDay

[Hoyoung MM @hmaeng]

Nothing new!

[Hoyoung MM @hmaeng]

@WPAOG 1 yr to go for the Class of 2026!! Ewwww😍

[Hoyoung MM @hmaeng]

@sesiegler Sorry, Sara. Just reading this. I hope you get the myriads of symptoms controlled soon. Get those steroid out of tour list soon or at least bring down to a physiologic level. Sent you a message. HUGS

[ImmunityBio, Inc. @ImmunityBio]

Today, we announced that we are studying ANKTIVA in combination with the investigational AdHER2DC cancer vaccine as a potential treatment for endometrial cancer, aiming to improve outcomes and sustain clinical response. Learn more: https://t.co/fH39lTt1eU

[Hoyoung MM @hmaeng]

@balinoruo @sesiegler Oh no, 💐 feel better.

[Hoyoung MM @hmaeng]

@Julian_WKL @cwruim Congratulations!!! 💕

[NIH Clinical Center @NIHClinicalCntr]

Researchers @NIHClinicalCntr seek patients with HER2-expressing #EndometrialCancer that returned or got worse after treatment. To participate, contact the NIH Office of Patient Recruitment at 866-444-1134 or visit https://t.co/KRoFSR6fF5 and reference NIH study #001557-C

[NIH Clinical Center @NIHClinicalCntr]

Volunteers with HER2-expressing #EndometrialCancer are needed for a #CancerVaccine #CancerImmunotherapy research study. To participate, contact the NIH Office of Patient Recruitment at 866-444-1134 or visit https://t.co/KRoFSR5HPx.  Refer to study#001557-C.

[Hoyoung MM @hmaeng]

@NCICCR_MOS @RaissaKentsa @DalelaDisha @nih_nhlbi @NCIResearchCtr Congrats!! @DrKateLurain and I are alumni there too!